<?xml version="1.0" encoding="UTF-8"?>
<p>MERS-CoV causes respiratory infection called MERS or camel flu. Mortality rate is around 33%, and there is no specific treatment or vaccine for the disease till now. MMF is one of the retrieved medications investigated for its antiviral efficacy for MERS. Although good inhibitory effects were noted in 
 <italic>in vitro</italic> studies,
 <sup>
  <xref rid="bibr95-1759720X20947296" ref-type="bibr">95</xref>
 </sup> all marmosets treated with MMF experienced severe and fatal disease.
 <sup>
  <xref rid="bibr96-1759720X20947296" ref-type="bibr">96</xref>
 </sup>
</p>
